Results 171 to 180 of about 7,395 (191)

Aciclovir and acute kidney injury: putting the research in context

Archives of Disease in Childhood, 2020
Drug-induced kidney injury is one of the most common causes of acute kidney injury (AKI) in children. As well as induction of AKI, drug-induced nephrotoxicity can also affect long-term renal function and lead to chronic kidney disease (CKD) and end-stage
Tania Sarsam, S. McWilliam
semanticscholar   +1 more source

Mucoadhesive plasticized system of branched poly(lactic-co-glycolic acid) with aciclovir

Drug Development and Industrial Pharmacy, 2016
Commercially available antibacterial semisolid preparations intended for topical application provide only short-term drug release. A sustained kinetics is possible by exploitation of a biodegradable polymer carrier.
E. Šnejdrová, Martin Drastik, M. Dittrich, P. Kastner, Jana Nguyenova   +4 more
semanticscholar   +1 more source

Aciclovir

Reactions weekly, 2023

semanticscholar   +1 more source

Successful Prevention of Varicella Outbreak With Oral Aciclovir Following Party for Pediatric Oncology Patients.

Journal of pediatric hematology/oncology, 2018
Rachel Hill, RD, CSO, LD, CNSC* Madeleine Bricker, OMS-II† Lisa Bashore, PhD, RN, CPNP, CPON*‡ Stefanie Rapisand, RN, MSN, FNP-BC, CPN* Kenneth M. Heym, MD* Tyler Hamby, PhD†§ Departments of *Pediatric Hematology/Oncology §Research Operations, Cook ...
R. Beckingham, S. Chamberlain, J. Bate
semanticscholar   +1 more source

Aciclovir prophylaxis after varicella zoster exposure in pregnancy

Drug and therapeutics bulletin, 2023
J. Girling
semanticscholar   +1 more source

Insuffisance rénale aiguë sous aciclovir

Néphrologie & Thérapeutique, 2022
S. Bouhjar, S. Boujnane, M. Chettati, W. Fadili, I. Laouad   +4 more
semanticscholar   +1 more source

In Vivo studies of Ophthalmic Ocular Insert Containing Aciclovir

, 2017
Aciclovir is an antiviral drug used to treat viral infections like herpes simplex virus. The aim of the present research work was to develop ocular inserts of aciclovir and evaluate their drug release for both in vitro and in vivo.
S. Valarmathi, S. Shanmugam, S. Kumar, P. Shanmugasundaram   +3 more
semanticscholar   +1 more source

Anti-infective prophylaxis with aciclovir and cotrimoxazole to reduce the rate of infections and therapy-associated deaths in elderly patients with DLBCL undergoing R-CHOP immunochemotherapy.

, 2017
7539Background: To study if anti-infective prophylaxis with aciclovir and cotrimoxazole is effective in preventing infections in pts.
N. Murawski, Josif Amam, B. Altmann, M. Ziepert, M. Haenel, A. Viardot, A. Neubauer, G. Held, L. Truemper, C. Schmidt, L. Kanz, M. Hallek, N. Schmitz, T. Heintges, C. Koelbel, V. Poeschel, M. Pfreundschuh   +16 more
semanticscholar   +1 more source

Formulation Development and Evaluation of Opthalmic ocusert containing Aciclovir

, 2016
The aim of formulating aciclovir occusert was to prolong the drug residence time after ocular administration to achieve the controlled release of drug.
S. Shanmugam, S. Valarmathi, S. Kumar, P. Shanmugasundaram, M. Senthilkumar   +4 more
semanticscholar   +1 more source

Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients.

Journal of Clinical Virology, 2020
V. Anton-Vazquez, V. Mehra, J. Mbisa, D. Bradshaw, T. Basu, M. Daly, G. Mufti, A. Pagliuca, V. Potter, M. Zuckerman   +9 more
semanticscholar   +1 more source